We take a look at 4 Pharma & Biotech companies whose share prices rallied in October on the back of positive announcements.

We recently published a list of 10 Top Performing European Stocks Heading into 2025. In this article, we are going to take a ...

All doses of Novo Nordisk’s blockbuster diabetes and obesity drugs were listed as available on the FDA shortage list as of ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

Verona Pharma (Nasdaq: VRNA) is already recording millions of dollars in revenue after launching its lead drug in August ...

Discover the major biotech partnerships, collaborations, and mergers and acquisitions that made headlines in October 2024.

Out of the top 40 brands, Monocef /Calpol /Azithral /Pantop posted a decline of 26%/26%/24%/10% YoY in Oct-24, adds the brokerage.

Independent advisers to the U.S. Food and Drug Administration on Thursday voted against recommending Lexicon Pharmaceuticals' ...

Supernus Pharmaceuticals is reaping the benefits of its ADHD drug Qelbree, with strong Q3 results and upwardly revised ...

Dilip Shanghvi's journey from the beginning with just Rs 2,000 highlights the importance of resilience, adaptability, and ...

Belgium has solidified its position as a European leader in pharmaceutical research and development with a daily investment ...